Lenvatinib

Also known as E7080 and Lenvima.

Latest news on lenvatinib

13 October 2026
Merck unveils first Phase 3 results for intismeran and sac‑TMT at ESMO 2026

Phase 3 intismeran combo improved recurrence‑free and distant metastasis‑free survival in resected stage IIB–IV melanoma; sac‑TMT and KEYNOTE‑C93 report pivotal endometrial cancer findings; >90 additional abstracts.